| | | | | | | | | | | | | | | |
| |
 | Issue Date FY: 2024 ( Subtotal = $586,949 ) |
| 2024 | 2024 | BLOODWORKS | 921 TERRY AVE | SEATTLE | WA | 98104 | KING | USA | Blood Diseases and Resources Research | 000 | 5 | 7/15/2024 | NON-COMPETING CONTINUATION | $586,949 |
|
 | Issue Date FY: 2023 ( Subtotal = $598,928 ) |
| 2023 | 2023 | BLOODWORKS | 921 TERRY AVE | SEATTLE | WA | 98104 | KING | USA | Blood Diseases and Resources Research | 000 | 4 | 8/31/2023 | NON-COMPETING CONTINUATION | $598,928 |
|
 | Issue Date FY: 2022 ( Subtotal = $477,739 ) |
| 2022 | 2022 | BLOODWORKS | 921 TERRY AVE | SEATTLE | WA | 98104 | KING | USA | Blood Diseases and Resources Research | 000 | 3 | 7/26/2022 | NON-COMPETING CONTINUATION | $477,739 |
|
 | Issue Date FY: 2021 ( Subtotal = $477,739 ) |
| 2021 | 2021 | BLOODWORKS | 921 TERRY AVE | SEATTLE | WA | 98104 | KING | USA | Blood Diseases and Resources Research | 000 | 2 | 7/15/2021 | NON-COMPETING CONTINUATION | $477,739 |
|
 | Issue Date FY: 2020 ( Subtotal = $507,279 ) |
| 2020 | 2020 | BLOODWORKS | 921 TERRY AVE | SEATTLE | WA | 98104 | KING | USA | Blood Diseases and Resources Research | 000 | 1 | 7/31/2020 | NEW | $507,279 |
|
|